{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T18:01:56Z","timestamp":1784484116883,"version":"3.55.0"},"reference-count":14,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,1,23]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>Very severe intrahepatic cholestasis of pregnancy (ICP) characterised by total serum bile acid (TSBA) &gt;100\u2009umol\/L is associated with an increased stillbirth risk of 3.4%. Patients exposed to thiopurines may be at increased risk of ICP. We report a case of a mid-30-year-old primigravida who presented at 27+2\/40 with a 7-week history of pruritus and jaundice and was diagnosed with very severe ICP (TSBA=117\u2009\u00b5mol\/L). She had inflammatory bowel disease, controlled on azathioprine 200\u2009mg daily. Thiopurine metabolites ratio, 6-methylmercaptopurine: 6-thioguanine nucleotide (6MMP:TGN) was 34 at 12\/40 and 21 at 27\/40. Cessation of azathioprine precipitated a TSBA fall to 31\u2009\u00b5mol\/L within 7\u2009days. A multidisciplinary plan was made in conjunction with the patient for delivery between 35 and 36 weeks. This case highlights the risks of thiopurine use in pregnancy and supports ceasing azathioprine treatment immediately at the onset of ICP, avoiding TSBA levels rising.<\/jats:p>","DOI":"10.1136\/bcr-2025-270556","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:46:49Z","timestamp":1770828409000},"page":"e270556","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Very severe intrahepatic cholestasis of pregnancy contributed to by azathioprine dosing"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6468-0138","authenticated-orcid":false,"given":"Lyra","family":"Meehan","sequence":"first","affiliation":[{"name":"Women's and Children\u2019s, Grampians Health, Ballarat, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Saitta","sequence":"additional","affiliation":[{"name":"Internal Medicine, Grampians Health, Ballarat, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Frawley","sequence":"additional","affiliation":[{"name":"Women's and Children\u2019s, Grampians Health, Ballarat, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajith","family":"Kattiparambil Gangadharan","sequence":"additional","affiliation":[{"name":"Internal Medicine, Grampians Health, Ballarat, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9692-8118","authenticated-orcid":false,"given":"David","family":"Langsford","sequence":"additional","affiliation":[{"name":"Internal Medicine, Grampians Health, Ballarat, Victoria, Australia"},{"name":"Medicine, The University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"2026071910152106000_19.2.e270556.1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20336"},{"key":"2026071910152106000_19.2.e270556.2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.222893"},{"key":"2026071910152106000_19.2.e270556.3","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.22948"},{"key":"2026071910152106000_19.2.e270556.4","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.3748\/wjg.v23.i22.4102","article-title":"Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study","volume":"23","author":"Koller","year":"2017","journal-title":"World J Gastroenterol"},{"key":"2026071910152106000_19.2.e270556.5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/ecco-jcc\/jjae023","article-title":"Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing","volume":"18","author":"Prentice","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026071910152106000_19.2.e270556.6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.tjog.2023.07.023","article-title":"Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature","volume":"62","author":"Frank Wolf","year":"2023","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2026071910152106000_19.2.e270556.7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejogrb.2020.05.002","article-title":"Azathioprine-induced cholestasis of pregnancy-A new insight on azathioprine safety in pregnancy","volume":"250","author":"Lauterbach","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026071910152106000_19.2.e270556.8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2021.102083","article-title":"Intrahepatic cholestasis of pregnancy associated with azathioprine: A case series","volume":"50","author":"C\u00e9ruti","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2026071910152106000_19.2.e270556.9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/14740338.2023.2234813","article-title":"Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy","volume":"22","author":"Selinger","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"2026071910152106000_19.2.e270556.10","article-title":"Azathioprine Associated with Intrahepatic Cholestasis in a Patient with Twin Pregnancy after a Second Kidney Transplant","volume":"11","author":"Khedr","year":"2024","journal-title":"Eur J Case Rep Intern Med"},{"key":"2026071910152106000_19.2.e270556.11","doi-asserted-by":"publisher","DOI":"10.3109\/01443615.2012.716106"},{"key":"2026071910152106000_19.2.e270556.12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cld.1132","article-title":"Genetic Disorders of Bile Acid Transport","volume":"18","author":"Henkel","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"2026071910152106000_19.2.e270556.13","article-title":"Pharmacological interventions for treating intrahepatic cholestasis of pregnancy","volume":"7","author":"Walker","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2026071910152106000_19.2.e270556.14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","article-title":"Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-270556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T17:15:31Z","timestamp":1784481331000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-270556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,11]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bcr-2025-270556"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-270556","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}